# Attitudes to Drug Policy in Australia, 2001–2022/23: What Does This Mean for Drug Policy Reform in Australia?

**Authors:** Zachary Lloyd, Amanda Roxburgh

PMC · DOI: 10.1111/dar.70130 · Drug and Alcohol Review · 2026-03-15

## TL;DR

This paper examines changes in Australian public opinion and media coverage on drug policies from 2001 to 2023, highlighting strong support for harm reduction and a health-focused approach.

## Contribution

The study provides updated insights into public attitudes and media trends in drug policy in Australia over two decades.

## Key findings

- Australians strongly support harm reduction measures like needle programs and supervised injecting facilities.
- Public support for legalizing drugs like methamphetamine and heroin remains very low.
- Media coverage increasingly focuses on methamphetamine and decriminalisation efforts.

## Abstract

We are at a critical juncture for drug policy reform. Toxic drug supply is driving unprecedented deaths in North America, with countries calling for decriminalisation. Policy reform in Australia has occurred in some states (e.g., decriminalisation in the Australian Capital Territory), stalling in others (e.g., the second supervised injecting facility [SIF] in Victoria). The objectives of this paper are to present trends in attitudes to drug policy in Australia, 2001–2022/23 and media reporting of related policies, to explore how public opinion and media attention have changed over time.

Analysis of (i) National Drug Strategy Household Survey data on attitudes to drugs/drug policies; and (ii) Factiva for media reporting.

In 2022/23, Australians supported needle and syringe programs (67.8%), SIFs (58.3%), take home naloxone (60.9%) and drug checking services (64.4%). They opposed legalisation of methamphetamine (86.6%), heroin (85.6%), cocaine (78.2%) and ecstasy (75.8%), while a larger proportion supported cannabis legalisation (44.6%). Australians supported a health response to possession of drugs (57.3% for methamphetamine, 80.9% for cannabis) rather than a criminal response. Methamphetamine was increasingly reported as the drug of most concern (2.9%–42.5%), decreasing for heroin (44.9%–11.4%), 2001–2022/23. Methamphetamine media articles increased (272–2426); heroin decreased (2136–973), 2000–2023. Mentions increased for SIFs (spiking at 175, 2019) and decriminalisation/legalisation (spiking at 242, 2019).

Support for harm reduction remains high and low for legalisation. Media focused on methamphetamine, SIFs and decriminalisation/legalisation. Despite opposition towards legalisation, most Australians favoured a health response to drug use.

Australians are largely supportive of harm reduction initiatives.Support for the legalisation of heroin, methamphetamine, cocaine and ecstasy is low.Australians, however, predominantly prefer a health response for possession of illicit substances.Media counts were highest for methamphetamine, injecting rooms and decriminalisation.

Australians are largely supportive of harm reduction initiatives.

Support for the legalisation of heroin, methamphetamine, cocaine and ecstasy is low.

Australians, however, predominantly prefer a health response for possession of illicit substances.

Media counts were highest for methamphetamine, injecting rooms and decriminalisation.

## Linked entities

- **Chemicals:** methamphetamine (PubChem CID 1206), heroin (PubChem CID 5462328), cocaine (PubChem CID 2826), ecstasy (PubChem CID 1615), naloxone (PubChem CID 4425)

## Full-text entities

- **Diseases:** overdose (MESH:D062787), Injecting (MESH:C000719195), poisonings (MESH:D011041), fatalities (MESH:C565541), deaths (MESH:D003643), Toxic (MESH:D064420), drug (MESH:D000081015)
- **Chemicals:** morphine (MESH:D009020), Ice (MESH:D007053), Methamphetamine (MESH:D008694), Steroids (MESH:D013256), hydromorphone (MESH:D004091), ecstasy (-), Heroin (MESH:D003932), methadone (MESH:D008691), Pethidine (MESH:D008614), Naloxone (MESH:D009270), alcohol (MESH:D000438), fentanyl (MESH:D005283), crack cocaine (MESH:D016578), cocaine (MESH:D003042)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12989179/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12989179/full.md

## References

87 references — full list in the complete paper: https://tomesphere.com/paper/PMC12989179/full.md

---
Source: https://tomesphere.com/paper/PMC12989179